Detalhe da pesquisa
1.
Evaluating the impact of chemotherapy-induced nausea and vomiting on daily functioning in patients receiving dexamethasone-sparing antiemetic regimens with NEPA (netupitant/palonosetron) in the cisplatin setting: results from a randomized phase 3 study.
BMC Cancer
; 22(1): 915, 2022 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35999527
2.
Dexamethasone-Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High-Dose Cisplatin: A Randomized Noninferiority Study.
Oncologist
; 26(10): e1854-e1861, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34101934
3.
Cardiovascular safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients: a prospective evaluation.
Future Oncol
; 14(5): 443-448, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29318908
4.
Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients.
Future Oncol
; 11(6): 965-73, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25760977
5.
Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer.
Future Oncol
; 10(6): 975-83, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24295376
6.
Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting.
Future Oncol
; 10(10): 1741-50, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24641206
7.
A multicenter phase 2 single arm study of cabozantinib in patients with advanced or unresectable renal cell carcinoma pre-treated with one immune-checkpoint inhibitor: The BREAKPOINT trial (Meet-Uro trial 03).
Tumori
; 109(1): 129-137, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36447337
8.
Exploratory analysis of the effect of a dexamethasone-sparing regimen for prophylaxis of cisplatin-induced emesis on food intake (LUNG-NEPA study).
Sci Rep
; 13(1): 1257, 2023 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36690734
9.
U-CHANGE Project: a multidimensional consensus on how clinicians, patients and caregivers may approach together the new urothelial cancer scenario.
Front Oncol
; 13: 1186103, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37576880
10.
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors.
J Natl Cancer Inst
; 115(12): 1605-1615, 2023 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37563779
11.
Central nervous system metastases from castration-resistant prostate cancer in the docetaxel era.
J Neurooncol
; 107(1): 191-6, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21989810
12.
Cisplatin-based chemotherapy for the treatment of metastatic collecting duct carcinomas: A real-world, retrospective analysis.
Front Oncol
; 12: 939953, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36330500
13.
Playing the Devil's Advocate: Should We Give a Second Chance to mTOR Inhibition in Renal Clear Cell Carcinoma? - ie Strategies to Revert Resistance to mTOR Inhibitors.
Cancer Manag Res
; 13: 7623-7636, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34675658
14.
GU-CA-COVID: a clinical audit among Italian genitourinary oncologists during the first COVID-19 outbreak.
Ther Adv Urol
; 13: 17562872211054302, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34707691
15.
Integration of Lipidomics and Transcriptomics Reveals Reprogramming of the Lipid Metabolism and Composition in Clear Cell Renal Cell Carcinoma.
Metabolites
; 10(12)2020 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33322148
16.
Lack of Cumulative Toxicity Associated With Cabazitaxel Use in Prostate Cancer.
Medicine (Baltimore)
; 95(2): e2299, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26765406
17.
Optimal sequence of bone target drugs in metastatic prostatic cancer.
Expert Rev Anticancer Ther
; 15(8): 923-9, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26070344
18.
Experience with pazopanib in the treatment of metastatic renal cell carcinoma: a monocentric experience.
Tumori
; 100(4): 165e-8e, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25296611
19.
Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells.
Carcinogenesis
; 26(5): 883-91, 2005 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15705602
20.
Endothelial cells in the bone marrow of patients with multiple myeloma.
Blood
; 102(9): 3340-8, 2003 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12855563